Clinical Trial Update: Comparative Effectiveness Between Indomethacin and Pancreatic Stenting in the Prevention of Post ERCP Pancreatitis [Phase 3]

View source ↗

Summary

A Phase 3 trial from the Chinese University of Hong Kong is comparing indomethacin with pancreatic stenting to prevent post-endoscopic retrograde cholangiopancr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)
• Pancreatic stent

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Post ERCP Pancreatitis | Phase 3 | Status: RECRUITING